FEBRILE INFECTION-RELATED EPILEPSY SYNDROME

FEBRILE INFECTION-RELATED EPILEPSY SYNDROME was reported 31 times

FEBRILE INFECTION-RELATED EPILEPSY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 8 0.0010
1 Interleukin-1 Receptor Antagonist [EPC] 11 0.0007
2 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006
3 Carnitine Analog [EPC] 2 0.0005
4 Osmotic Diuretic [EPC] 1 0.0002
5 Human Immunoglobulin G [EPC] 3 0.0001
6 General Anesthetic [EPC] 4 0.0001
7 Androgen [EPC] 2 0.0001
8 Nonergot Dopamine Agonist [EPC] 1 0.0001
9 Carbonic Anhydrase Inhibitor [EPC] 1 0.0000
10 Topoisomerase Inhibitor [EPC] 3 0.0000
11 Anti-epileptic Agent [EPC] 7 0.0000
12 Glycopeptide Antibacterial [EPC] 2 0.0000
13 Penem Antibacterial [EPC] 1 0.0000
14 Rifamycin Antibacterial [EPC] 1 0.0000
15 Interleukin-17A Antagonist [EPC] 1 0.0000
16 Benzodiazepine [EPC] 15 0.0000
17 Mood Stabilizer [EPC] 4 0.0000
18 Proteasome Inhibitor [EPC] 2 0.0000
19 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
20 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
21 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
22 Tetracycline-class Drug [EPC] 1 0.0000
23 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
24 Janus Kinase Inhibitor [EPC] 2 0.0000
25 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
26 Corticosteroid [EPC] 12 0.0000
27 Alkylating Drug [EPC] 2 0.0000
28 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
29 Proton Pump Inhibitor [EPC] 2 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
31 Insulin Analog [EPC] 1 0.0000